Jiannong Li
Jiannong Li
Verified email at
Cited by
Cited by
Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network
A Smith, S Crouch, S Lax, J Li, D Painter, D Howell, R Patmore, A Jack, ...
British journal of cancer 112 (9), 1575-1584, 2015
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer
J Li, U Rix, B Fang, Y Bai, A Edwards, J Colinge, KL Bennett, J Gao, ...
Nature chemical biology 6 (4), 291-299, 2010
Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor–dependent human lung cancer cells
A Edwards, J Li, P Atadja, K Bhalla, EB Haura
Molecular cancer therapeutics 6 (9), 2515-2524, 2007
Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
X Zhao, T Lwin, A Silva, B Shah, J Tao, B Fang, L Zhang, K Fu, C Bi, J Li, ...
Nature communications 8 (1), 14920, 2017
A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells
J Li, J Viallet, EB Haura
Cancer chemotherapy and pharmacology 61, 525-534, 2008
Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors
Y Bai, J Li, B Fang, A Edwards, G Zhang, M Bui, S Eschrich, S Altiok, ...
Cancer research 72 (10), 2501-2511, 2012
Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non–small cell lung cancer
T Yoshida, G Zhang, MA Smith, AS Lopez, Y Bai, J Li, B Fang, J Koomen, ...
Clinical Cancer Research 20 (15), 4059-4074, 2014
Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA
H Chen, L Teng, JN Li, R Park, DE Mold, J Gnabre, JR Hwu, WN Tseng, ...
Journal of medicinal chemistry 41 (16), 3001-3007, 1998
MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion
J Gao, MJ McConnell, B Yu, J Li, JM Balko, EP Black, JO Johnson, ...
International journal of oncology 35 (2), 337-345, 2009
ZEB1 mediates acquired resistance to the epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer
T Yoshida, L Song, Y Bai, F Kinose, J Li, KC Ohaegbulam, ...
PloS one 11 (1), e0147344, 2016
GSK3 alpha and beta are new functionally relevant targets of tivantinib in lung cancer cells
LL Remsing Rix, BM Kuenzi, Y Luo, E Remily-Wood, F Kinose, G Wright, ...
ACS chemical biology 9 (2), 353-358, 2014
Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma
I Smalley, E Kim, J Li, P Spence, CJ Wyatt, Z Eroglu, VK Sondak, ...
EBioMedicine 48, 178-190, 2019
Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity
G Zhang, B Fang, RZ Liu, H Lin, F Kinose, Y Bai, U Oguz, ...
Journal of proteome research 10 (1), 305-319, 2011
Linc-ing circulating long non-coding RNAs to the diagnosis and malignant prediction of intraductal papillary mucinous neoplasms of the pancreas
JB Permuth, DT Chen, SJ Yoder, J Li, AT Smith, JW Choi, J Kim, ...
Scientific reports 7 (1), 10484, 2017
Fragment-based and structure-guided discovery and optimization of Rho kinase inhibitors
R Li, MP Martin, Y Liu, B Wang, RA Patel, JY Zhu, N Sun, R Pireddu, ...
Journal of medicinal chemistry 55 (5), 2474-2478, 2012
Combined BRAF and HSP90 Inhibition in Patients with Unresectable BRAFV600E-Mutant Melanoma
Z Eroglu, YA Chen, GT Gibney, JS Weber, RR Kudchadkar, NI Khushalani, ...
Clinical Cancer Research 24 (22), 5516-5524, 2018
Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms
J Li, K Bennett, A Stukalov, B Fang, G Zhang, T Yoshida, I Okamoto, ...
Molecular systems biology 9 (1), 705, 2013
Characterizing tyrosine phosphorylation signaling in lung cancer using SH2 profiling
K Machida, S Eschrich, J Li, Y Bai, J Koomen, BJ Mayer, EB Haura
PloS one 5 (10), e13470, 2010
Inhibition of microtubule polymerization by 3-bromopropionylamino benzoylurea (JIMB01), a new cancericidal tubulin ligand
JN Li, DQ Song, YH Lin, QY Hu, L Yin, G Bekesi, JF Holland, JD Jiang
Biochemical pharmacology 65 (10), 1691-1699, 2003
Double blockade of cell cycle at G1-S transition and M phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand
JD Jiang, L Denner, YH Ling, JN Li, A Davis, Y Wang, Y Li, J Roboz, ...
Cancer research 62 (21), 6080-6088, 2002
The system can't perform the operation now. Try again later.
Articles 1–20